Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar JustCommonSense (< 20) Submitted: 7/13/2012 10:12:17 PM : Outperform Start Price: $10.99 ARNA Score: -50.77

Just a wait and pay me play

Featured Broker Partners


Advertisement